Editorial · 2021
EditorialPublished 15 Mar 2021
Editorial Note On Hepatocellular Carcinoma
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The combination of atezolizumab and bevacizumab showed encouraging anticancer activity and safety in a very section 1b trial involving patients with unresectable hepatoma. In a world, open-label, section three trial, patients with unresectable hepatocarcinoma United Nations agency had not antecedently received general treatment were haphazardly allotted in a very 2:1 quantitative relation to receive either atezolizumab and bevacizumab or sorafenib till unacceptable noxious effects occurred or there was a loss of clinical profit. The coprimary finish points were overall survival and progression-free survival within the intention-to-treat population, as assessed at associate freelance review facility per Response analysis Criteria in Solid Tumors, version 1.1
Keywords
Subjects
Gastroenterology & HepatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 2021
A Brief Note on Hepatocellular carcinoma
Article · 12 Jun 2026
Progression of Hepatocellular Carcinoma in Modern Clinical Contexts
Article · 18 Aug 2025
The anti-inflammatory effect of Artemisia absinthium extract on cell growth through targeting PI3K/Akt/mTOR pathway in human hepatocellular carcinoma cell line
Commentary · 29 May 2025
Advances in Hepatocellular Carcinoma Treatment
More from this journal
The newest in Journal of Gastroenterology and Digestive Diseases.
Research article · 10 Aug 2025
Epidemiological, diagnostic and evolutionary aspects of decompensated cirrhosis in patients hospitalized in an overseas hepato-gastroenterology department.
Perspective · 30 Apr 2025
Sarcopenia and Protein Intake in the Elderly: Metabolic Considerations for Healthy Aging
Research article · 30 Apr 2025
COMPARATIVE ANALYSIS OF IN-VITRO DISSOLUTION RATES FOR SACHET FORMULATIONS OF MESALAMINE (1G AND 2 G) IN INDIA
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Gastroenterology and Digestive Diseases
- SubjectGastroenterology & Hepatology
- BylineArticles whose byline prints “Prathyusha.k”

